S&P 500 7,664.69 ▲ 33.22 (+0.44%) DOW 52,995.35 ▲ 228.47 (+0.43%) NASDAQ 26,189.76 ▲ 89.99 (+0.34%) US Markets Closed â€ĸ 05:31 PM ET

HKPD

Cellyan Biotechnology Co., Ltd

Price Chart

No historical data available

Latest Quote

$0.33

-0.01 (-4.00%)
Current Price
Previous Close $0.35
Open $0.35
Day High $0.36
Day Low $0.32
Volume 24,637
Fetched: 2026-09-01T11:03:25
Stock Information
Shares Outstanding 41.35M
Total Debt $1.26M
Cash Equivalents $222K
Revenue $13.43M
Net Income $-1.14M
Sector Healthcare
Industry Medical Distribution
Market Cap $16.17M
EPS (TTM) $-0.07
Exchange NCM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products. The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

📰 Latest News
No news articles available at the moment. Check back later for updates on HKPD.
Period:
Loading...
Income Statement (Annual)
Metric 2025-03-31 2024-03-31 2023-03-31
Revenue
Reconciled Cost Of Revenue $17,898,659 $13,129,699 $9,817,066
Cost Of Revenue $17,898,659 $13,129,699 $9,817,066
Total Revenue $20,313,818 $16,688,364 $12,555,991
Operating Revenue $20,313,818 $16,688,364 $12,555,991
Expenses
Interest Expense $97,667 $82,766 $23,242
Total Expenses $20,113,052 $15,015,116 $11,478,917
Other Income Expense $-68,728 $-64,987 $-33,281
Other Non Operating Income Expenses $-10,516 $-2,470 $-2,041
Net Non Operating Interest Income Expense $-95,926 $-82,292 $-23,023
Interest Expense Non Operating $97,667 $82,766 $23,242
Operating Expense $2,214,393 $1,885,417 $1,661,851
Other Operating Expenses $-1,466 $-4,038 $-96,229
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-27,056 $1,329,717 $998,196
Net Interest Income $-95,926 $-82,292 $-23,023
Interest Income $1,741 $474 $219
Normalized Income $21,551 $1,384,232 $1,028,749
Net Income From Continuing And Discontinued Operation $-27,056 $1,329,717 $998,196
Total Operating Income As Reported $132,038 $1,608,261 $1,043,793
Net Income Common Stockholders $-27,056 $1,329,717 $998,196
Net Income $-27,056 $1,329,717 $998,196
Net Income Including Noncontrolling Interests $-27,056 $1,329,717 $998,196
Net Income Continuous Operations $-27,056 $1,329,717 $998,196
Pretax Income $36,112 $1,525,969 $1,020,770
Special Income Charges $-7,526 $708 $0
Interest Income Non Operating $1,741 $474 $219
Operating Income $200,766 $1,673,248 $1,077,074
Gross Profit $2,415,159 $3,558,665 $2,738,925
Per Share
Diluted EPS $-0.00 $0.12 $0.09
Basic EPS $-0.00 $0.12 $0.09
Other
Tax Effect Of Unusual Items $-9,605 $-8,002 $-687
Tax Rate For Calcs $0 $0 $0
Normalized EBITDA (Bullshit earnings) $1,265,362 $2,596,828 $1,789,838
Total Unusual Items $-58,212 $-62,517 $-31,240
Total Unusual Items Excluding Goodwill $-58,212 $-62,517 $-31,240
Reconciled Depreciation $1,073,371 $925,576 $714,586
EBITDA (Bullshit earnings) $1,207,150 $2,534,311 $1,758,598
EBIT $133,779 $1,608,735 $1,044,012
Diluted Average Shares $10,205,479 $11,000,000 $11,000,000
Basic Average Shares $10,205,479 $11,000,000 $11,000,000
Diluted NI Availto Com Stockholders $-27,056 $1,329,717 $998,196
Tax Provision $63,168 $196,252 $22,574
Gain On Sale Of Ppe $-7,526 $-10,851 $0
Gain On Sale Of Business $0 $11,559 $0
Gain On Sale Of Security $-50,686 $-63,225 $-31,240
Selling General And Administration $2,215,859 $1,889,455 $1,758,080
Minority Interests - $0 $0
Fetched: 2026-08-30
Balance Sheet (Annual)
Metric 2025-03-31 2024-03-31 2023-03-31
Assets
Net Tangible Assets $4,893,332 $4,221,834 $581,213
Total Assets $9,417,276 $8,667,228 $3,406,754
Total Non Current Assets $690,171 $865,518 $658,290
Goodwill And Other Intangible Assets $96,437 $31,825 $4,029
Other Intangible Assets $96,437 $31,825 $4,029
Current Assets $8,727,105 $7,801,710 $2,748,464
Current Deferred Assets $0 $1,260,075 $0
Restricted Cash $400 $7,682 $0
Prepaid Assets $447,912 $1,262,351 $302,555
Inventory $559,982 $933,299 $190,887
Receivables $4,713,260 $3,718,728 $1,730,409
Accounts Receivable $4,655,951 $3,698,757 $1,646,491
Allowance For Doubtful Accounts Receivable $0 $0 $0
Gross Accounts Receivable $4,655,951 $3,698,757 $1,646,491
Cash Cash Equivalents And Short Term Investments $3,005,551 $619,575 $524,613
Cash And Cash Equivalents $748,721 $619,575 $524,613
Cash Financial $748,721 $619,575 $524,613
Other Receivables - - $236,359
Debt
Net Debt $1,126,634 $714,898 -
Total Debt $2,374,870 $2,086,813 $691,076
Long Term Debt And Capital Lease Obligation $1,510,209 $1,237,112 $271,452
Long Term Debt $1,503,797 $1,119,276 $116,862
Current Debt And Capital Lease Obligation $864,661 $849,701 $419,624
Current Debt $371,558 $215,197 $62,353
Other Current Borrowings $371,558 $180,493 $62,353
Liabilities
Total Liabilities Net Minority Interest $4,427,507 $4,413,569 $2,821,512
Total Non Current Liabilities Net Minority Interest $1,510,209 $1,237,112 $271,452
Current Liabilities $2,917,298 $3,176,457 $2,550,060
Current Deferred Liabilities $124,507 $191,066 $268,028
Payables And Accrued Expenses $1,928,130 $2,135,690 $1,862,408
Payables $1,903,065 $2,101,910 $1,796,612
Other Payable $68,885 $59,267 $82,610
Total Tax Payable $105,058 $218,831 $22,543
Accounts Payable $1,727,809 $1,323,135 $1,400,644
Equity
Common Stock Equity $4,989,769 $4,253,659 $585,242
Total Equity Gross Minority Interest $4,989,769 $4,253,659 $585,242
Stockholders Equity $4,989,769 $4,253,659 $585,242
Gains Losses Not Affecting Retained Earnings $10,819 $-4,858 $-4,342
Other Equity Adjustments $10,819 $-4,858 $-4,342
Retained Earnings $1,504,052 $1,531,108 $201,391
Other Equity Interest - $-300,000 $-6,843
Other
Ordinary Shares Number $11,000,000 $11,000,000 $11,000,000
Share Issued $11,000,000 $11,000,000 $11,000,000
Tangible Book Value $4,893,332 $4,221,834 $581,213
Invested Capital $6,865,124 $5,588,132 $764,457
Working Capital $5,809,807 $4,625,253 $198,404
Capital Lease Obligations $499,515 $752,340 $511,861
Total Capitalization $6,493,566 $5,372,935 $702,104
Additional Paid In Capital $3,463,898 $3,017,409 $388,193
Capital Stock $11,000 $10,000 $6,843
Common Stock $11,000 $10,000 $6,843
Long Term Capital Lease Obligation $6,412 $117,836 $154,590
Current Deferred Revenue $124,507 $191,066 $268,028
Current Capital Lease Obligation $493,103 $634,504 $357,271
Line Of Credit $0 $34,704 $0
Current Accrued Expenses $25,065 $33,780 $65,796
Dueto Related Parties Current $1,313 $500,677 $290,815
Net PPE $593,734 $833,693 $654,261
Accumulated Depreciation $-141,841 $-87,550 $-49,207
Gross PPE $735,575 $921,243 $703,468
Leases $67,424 $48,493 $24,739
Other Properties $650,435 $855,139 $599,725
Machinery Furniture Equipment $17,716 $17,611 $79,004
Properties $0 $0 $0
Inventories Adjustments Allowances $0 $0 $0
Finished Goods $519,145 $879,422 $124,932
Raw Materials $40,837 $53,877 $65,955
Duefrom Related Parties Current $57,309 $19,971 $83,918
Other Short Term Investments $2,256,830 $0 -
Fetched: 2026-08-30
Cash Flow Statement (Annual)
Metric 2025-03-31 2024-03-31 2023-03-31
Free Cash Flow
Free Cash Flow $414,226 $-482,348 $1,609,374
Operating Activities
Operating Cash Flow $569,214 $-394,330 $1,727,079
Cash Flow From Continuing Operating Activities $569,214 $-394,330 $1,727,079
Operating Gains Losses $43,145 $-708 -
Investing Activities
Capital Expenditure $-154,988 $-88,018 $-117,705
Investing Cash Flow $-2,454,963 $-40,796 $-132,095
Cash Flow From Continuing Investing Activities $-2,454,963 $-40,796 $-132,095
Net Other Investing Changes - $13,993 $-14,390
Financing Activities
Issuance Of Capital Stock $4,300,000 $509,501 $0
Financing Cash Flow $1,995,114 $537,315 $-1,155,671
Cash Flow From Continuing Financing Activities $1,995,114 $537,315 $-1,155,671
Net Other Financing Charges $-1,377,579 $-345,217 -
Net Common Stock Issuance $4,300,000 $509,501 $0
Common Stock Issuance $4,300,000 $509,501 $0
Other
Repayment Of Debt $-2,516,404 $-1,769,416 $-1,344,879
Issuance Of Debt $1,589,097 $2,142,447 $189,208
Interest Paid Supplemental Data $97,667 $82,766 $57,327
Income Tax Paid Supplemental Data $294,831 $0 $0
End Cash Position $749,121 $627,257 $524,613
Beginning Cash Position $627,257 $524,613 $84,979
Effect Of Exchange Rate Changes $12,499 $455 $321
Changes In Cash $109,365 $102,189 $439,313
Net Issuance Payments Of Debt $-927,307 $373,031 $-1,155,671
Net Long Term Debt Issuance $-927,307 $373,031 $-1,155,671
Long Term Debt Payments $-2,516,404 $-1,769,416 $-1,344,879
Long Term Debt Issuance $1,589,097 $2,142,447 $189,208
Net Investment Purchase And Sale $-2,299,975 $0 $0
Purchase Of Investment $-2,299,975 $0 $0
Net Intangibles Purchase And Sale $-85,072 $-35,282 $-3,062
Purchase Of Intangibles $-85,072 $-35,282 $-3,062
Net PPE Purchase And Sale $-69,916 $-19,507 $-114,643
Sale Of PPE $0 $33,229 $0
Purchase Of PPE $-69,916 $-52,736 $-114,643
Change In Working Capital $-520,246 $-2,648,915 $14,297
Change In Other Working Capital $-163,462 $93,602 $337,533
Change In Payables And Accrued Expense $282,009 $91,032 $977,844
Change In Payable $282,009 $91,032 $977,844
Change In Account Payable $396,883 $-105,220 $955,270
Change In Tax Payable $-114,874 $196,252 $22,574
Change In Income Tax Payable $-114,874 $196,252 $22,574
Change In Inventory $378,199 $-741,950 $-191,155
Change In Receivables $-1,016,992 $-2,091,599 $-1,109,925
Changes In Account Receivables $-918,793 $-2,047,556 $-929,509
Depreciation Amortization Depletion $1,073,371 $925,576 $714,586
Depreciation And Amortization $1,073,371 $925,576 $714,586
Depreciation $1,073,371 $925,576 $714,586
Gain Loss On Investment Securities $43,145 - -
Gain Loss On Sale Of PPE $0 $10,851 $0
Gain Loss On Sale Of Business $0 $-11,559 $0
Net Income From Continuing Operations $-27,056 $1,329,717 $998,196
Change In Prepaid Assets - - $-180,416
Fetched: 2026-08-30